Parallax Volatility Advisers, L.P. Sage Therapeutics, Inc. Call Options Transaction History

Parallax Volatility Advisers, L.P.

  • $53.5 Billion
  • Q3 2024

Call Options

12 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$17.1 - $22.26 $1.57 Million - $2.05 Million
91,900 Added 680.74%
105,400 $2.28 Million
Q3 2023

Nov 14, 2023
BUY
$16.75 - $48.98 $226,125 - $661,230
13,500 New
13,500 $277,000
Q3 2022

Nov 14, 2022
BUY
$32.28 - $43.27 $6,456 - $8,654
200 New
200 $8,000
Q2 2022

Aug 15, 2022
SELL
$27.52 - $37.99 $173,376 - $239,337
-6,300 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$30.71 - $45.71 $193,473 - $287,973
6,300 New
6,300 $209,000
Q3 2021

Nov 15, 2021
SELL
$40.26 - $57.37 $1.66 Million - $2.37 Million
-41,300 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$54.88 - $79.29 $2.27 Million - $3.27 Million
41,300 New
41,300 $2.35 Million
Q4 2020

Feb 16, 2021
SELL
$58.41 - $89.06 $1.05 Million - $1.6 Million
-18,000 Closed
0 $0
Q3 2020

Nov 13, 2020
SELL
$41.13 - $62.45 $2.47 Million - $3.75 Million
-60,000 Reduced 76.92%
18,000 $1.1 Million
Q1 2019

May 15, 2019
BUY
$89.33 - $163.65 $6.3 Million - $11.5 Million
70,500 Added 940.0%
78,000 $12.4 Million
Q4 2018

Feb 14, 2019
SELL
$81.94 - $139.71 $204,850 - $349,275
-2,500 Reduced 25.0%
7,500 $718,000
Q4 2017

Feb 14, 2018
BUY
$60.72 - $167.34 $607,200 - $1.67 Million
10,000
10,000 $1.65 Million

Others Institutions Holding SAGE

# of Institutions
198
Shares Held
46.5M
Call Options Held
402K
Put Options Held
209K
View Full List

About Sage Therapeutics, Inc.

SAGE Quotes by TradingView
  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $326M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Parallax Volatility Advisers, L.P. Portfolio

Follow Parallax Volatility Advisers, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email